Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles
Introduction: There is a persisting global burden and considerable public health challenge by the plethora of ocular, genital and respiratory diseases caused by members of the Gram-negative bacteria of the genus Chlamydia. The major diseases are conjunctivitis and blinding trachoma, non-gonococcal u...
Main Authors: | Rajnish Sahu, Richa Verma, Saurabh Dixit, Joseph U. Igietseme, Carolyn M Black, Skyla Duncan, Shree R Singh, Vida A Dennis |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-03-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2018.1435279 |
Similar Items
-
The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses
by: Richa Verma, et al.
Published: (2018-10-01) -
Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge
by: Rajnish Sahu, et al.
Published: (2021-04-01) -
Cost-effectiveness of Chlamydia Vaccination Programs for Young Women
by: Kwame Owusu-Edusei, et al.
Published: (2015-06-01) -
Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine
by: Shakyra Richardson, et al.
Published: (2021-06-01) -
Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model
by: Samuel Rodrigues Dos Santos Junior, et al.
Published: (2020-09-01)